Jieqiong Li Selected Research

Jieqiong Li Research Topics

Disease

24	Immunoglobulin G4-Related Disease 01/2024 - 01/2019
5	Hypersensitivity (Allergy) 05/2023 - 10/2020
5	Infections 11/2022 - 08/2013
4	Pneumonia (Pneumonitis) 01/2024 - 01/2016
4	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2016
3	Inflammation (Inflammations) 01/2024 - 10/2020
3	Sialadenitis 12/2021 - 11/2019
3	Tuberculosis (Tuberculoses) 12/2020 - 11/2017
2	Exanthema (Rash) 07/2023 - 11/2019
2	Neoplasms (Cancer) 05/2023 - 01/2020
2	Thyroiditis 01/2023 - 01/2021
2	Thrombosis (Thrombus) 11/2022 - 01/2017
2	COVID-19 11/2022 - 01/2022
2	Autoimmune Pancreatitis 06/2022 - 07/2021
2	Dacryocystitis (Dacryoadenitis) 07/2021 - 11/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 11/2018
1	Major Depressive Disorder (Major Depressive Disorders) 12/2023
1	Mood Disorders (Mood Disorder) 12/2023
1	Stroke (Strokes) 12/2023
1	Dementia (Dementias) 12/2023
1	Schizophrenia (Dementia Praecox) 12/2023
1	Parkinson Disease (Parkinson's Disease) 12/2023
1	Wounds and Injuries (Trauma) 05/2023
1	Respiratory Syncytial Virus Infections 04/2023
1	Retroperitoneal Fibrosis 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Human Influenza (Influenza) 01/2023
1	Hyperbilirubinemia 08/2022
1	Atrophy 06/2022
1	Hypothyroidism 01/2021
1	Mediastinal Fibrosis 11/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Hydronephrosis 01/2020
1	Ureteral Obstruction 01/2020

Drug/Important Bio-Agent (IBA)

15	Immunoglobulin G (IgG)IBA 01/2024 - 08/2019
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2016
5	Immunoglobulin E (IgE)IBA 01/2021 - 01/2015
4	C-Reactive ProteinIBA 12/2023 - 11/2020
4	GlucocorticoidsIBA 07/2023 - 01/2019
4	VaccinesIBA 01/2023 - 01/2012
3	InterferonsIBA 01/2023 - 08/2021
2	SteroidsIBA 01/2024 - 01/2020
2	EnzymesIBA 07/2023 - 11/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2023 - 01/2020
2	sinovac COVID-19 vaccineIBA 11/2022 - 01/2022
2	CytokinesIBA 11/2022 - 08/2019
2	Inactivated VaccinesIBA 11/2022 - 08/2013
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 11/2020 - 10/2020
1	LipidsIBA 01/2024
1	Prostaglandins AIBA 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024
1	Leflunomide (Arava)FDA LinkGeneric 07/2023
1	CollagenIBA 04/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Unithiol (DMPS)IBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Antinuclear AntibodiesIBA 01/2023
1	fasciculol CIBA 01/2023
1	mangion-purified polysaccharide (Candida albicans)IBA 12/2022
1	COVID-19 VaccinesIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Small Cytoplasmic RNAIBA 11/2022
1	Interleukin-21 ReceptorsIBA 11/2022
1	AntioxidantsIBA 08/2022
1	Neuroprotective AgentsIBA 08/2022
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 08/2022
1	Interleukin-9 (Interleukin 9)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	LigandsIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Tuberculin (PPD)IBA 08/2021
1	FucoseIBA 03/2021
1	LectinsIBA 03/2021
1	Mannose (D-Mannose)IBA 03/2021
1	Polysaccharides (Glycans)IBA 03/2021
1	AntibodiesIBA 01/2021
1	LysophospholipidsIBA 01/2021
1	glyceric acidIBA 01/2021
1	Linoleic Acid (Linoleate)IBA 01/2021
1	CeramidesIBA 01/2021
1	Cytochromes c (Cytochrome c)IBA 01/2021
1	Uridine Diphosphate (UDP)IBA 01/2021
1	Uridine Diphosphate Galactose (UDP Galactose)IBA 01/2021
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2021
1	Uridine Triphosphate (UTP)IBA 01/2021
1	InflammasomesIBA 12/2020
1	Long Noncoding RNAIBA 08/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020

Therapy/Procedure

6	Therapeutics 07/2023 - 01/2017
2	Catheters 05/2023 - 01/2017
2	Aftercare (After-Treatment) 06/2022 - 08/2019
1	Central Venous Catheters 05/2023
1	Total Parenteral Nutrition 05/2023